## Abstract Progressive Supranuclear Palsy (PSP) is a progressive neurodegenerative disorder. In contrast to Parkinson's disease (PD) and dementia with Lewy bodies (DLB), replacement therapy with dopaminergic and cholinergic agents in PSP has been disappointing. The neurochemical basis for this is
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
✍ Scribed by Merle Ruberg; France Javoy-Agid; Etienne Hirsch; Bernard Scatton; Rémy Lheureux; Jean-Jacques Hauw; Charles Duyckaerts; Françloise Gray; Ariel Morel-Maroger; André Rascol; Michel Serdaru; Dr. Yves Agid
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 665 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Previous studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondeme
We studied sleep patterns for three nights in 10 subjects with moderate to severe progressive supranuclear palsy and correlated the findings with disease severity using quantitative measures of motor, cognitive, abd eye movement impairment. All subjects had severe insomnia, spending 2 to 6 hours awa
## Abstract Patients with orthostatic tremor (OT) can be classified as having “primary OT,” with or without postural arm tremor but no other abnormal neurological features, or “OT plus.” We describe a patient with OT, with postural tremor of the arms and restless legs syndrome (RLS), who developed